CJ 11974

Known as: CJ-11, 974, CJ-11,974, CJ-11974 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2010
0119992010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
BACKGROUND The current obesity epidemic is thought to be partly driven by over-consumption of sugar-sweetened diets and soft… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2002
2002
The anti-emetic effects of a novel tachykinin NK(1) receptor antagonist, ezlopitant ((2S,3S-cis)-2-diphenylmethyl)- N-[(2-methoxy… (More)
Is this relevant?
Review
2000
Review
2000
The introduction of serotonin 5-HT3 receptor antagonists into clinical practice allowed for a dramatic improvement in the… (More)
  • figure 1
  • table I
  • figure 2
  • table II
Is this relevant?
1999
1999
PURPOSE To determine the efficacy and safety of the neurokinin type 1 receptor antagonist CJ-11,974 for the control of high-dose… (More)
Is this relevant?